JERVELL AND LANGE NIELSEN SYNDROME

Clinical trials for JERVELL AND LANGE NIELSEN SYNDROME explained in plain language.

Never miss a new study

Get alerted when new JERVELL AND LANGE NIELSEN SYNDROME trials appear

Sign up with your email to follow new studies for JERVELL AND LANGE NIELSEN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Single-Dose heart drug tested for rare genetic condition

Disease control Completed

This study tested if a single intravenous dose of the drug diltiazem could safely shorten a dangerously long QT interval in adults with Jervell and Lange-Nielsen syndrome, a rare genetic disorder. The goal was to see if the drug could quickly reduce the heart's electrical instabi…

Matched conditions: JERVELL AND LANGE NIELSEN SYNDROME

Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control

Last updated Mar 16, 2026 15:23 UTC

JERVELL AND LANGE NIELSEN SYNDROME

Get alerted when new JERVELL AND LANGE NIELSEN SYNDROME trials appear

Single-Dose heart drug tested for rare genetic condition